Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes

NCT02730377 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1991

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: liraglutide
DRUG: alpha-glucosidase inhibitors
DRUG: DPP-4 inhibitors
DRUG: meglitinides
DRUG: SGLT-2 inhibitors
DRUG: sulphonylurea
DRUG: thiazolidinediones

Sponsor

Novo Nordisk A/S